Parenteral Nutrition Market To Reach USD 9,158.7 Million By 2028

According to the current analysis of Reports and Data, the global Parenteral Nutrition market was valued at USD 6,018.4 Million in 2020 and is expected to reach USD 9,158.7 Million by 2028, at a CAGR of 5.3%. Parenteral nutrition, or intravenous nutrition, is a method of bringing nutrition to your body through the veins. This form of diet is used to help people who cannot draw their essential nutrients from food. It has become a well-established intervention for the following indications: to maintain the lives of patients with short bowel syndrome; for perioperative use in patients with nutritional deprivation; to improve the quality of life of patients with inflammatory bowel disease; to help with the healing of enter-cutaneous and pancreatic fistulas. Also, used widely for hypermetabolic conditions such as sepsis, trauma, burns, and acquired immune deficiency syndrome; in neonatal and pediatric patients. It is considered to be a crucial source for meeting the nutritional needs of the body, especially in cancer patients. According to the World Health Organization, cancer is the second leading cause of death in the world and is responsible for about 9.6 million deaths in 2018.

Worldwide, approximately one in six deaths are due to cancer. With an increase in the number of cancer cases, the demand is expected to increase with a high CAGR. In addition to cancer, other health issues such as Crohn's disease, ischemic bowel disease, and increased prevalence of chronic diseases have increased adoption provide patients with essential nutrients. These nutrients are vital for maintaining high levels of energy, hydration, and strength. Besides, the growing gap between needs and the actual absorption of essential nutrients into the body is fueling up the industry.

Increase in geriatric population has led to an increase in the number of patients being admitted in the healthcare institutions and hospital eventually increasing the demand. Growing awareness and rise in disposable income has led to an increased adoption. Rising metabolic disorders and chronic illness is expected to further drive the growth of the industry. However, strict rules and regulations laid down by the government associated with approval of parenteral nutrition and lack of awareness among the people are the major hindrance for industry during 2021-2028.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2034

Further key findings from the report suggest:

Parenteral Nutrition market is growing at a CAGR of 4% in Asia Pacific followed by North America and Europe, with 5.8 % and 5.5% CAGR, respectively. High prevalence of chronic diseases among the geriatric population is expected to drive the market growth.

As of 2018, Single Dose Amino Acid Solution is the dominating the industry which holds 32.7% of the global market. North American regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions.

It is also considered to be a life-saving therapy, but it is complex. Some of these complications include infection, metabolic; however, management by an interdisciplinary nutritional support team can optimize outcomes for patients associated with this therapy.

Diseases of the bloodlines through which nutrition is administered can be severe and require interruption of diet, antibiotic intake, and line exchange which are some of the complications encountered during therapy.

Increased collaboration and partnership among key players is expected to increase the market share in the upcoming years. For example, Baxter International Inc. and Laboratoire Aguettant SAS have signed an exclusive worldwide licensing and distribution agreement for micronutrients, which are essential micronutrients used in therapy.

Increased government and non-governmental organization initiatives can increase the industry share. For example, on October 10, 2018, the American Parenteral and Enteral Nutrition Society (ASPEN), an organization that promotes the science and practice of clinical nutrition, and Baxter International Inc., a world leader in nutrition Clinical has published a series of educational videos on the proper use of parenteral nutrition.
To increase the market share, manufacturers are introducing new client-centered therapies. For example, infusion therapy, depending on the underlying disease, the solution contains a suitable active pharmaceutical ingredient.

In addition, the launch of innovative and compelling products is driving the growth of the market due to increased adoption. For example, the Celsite Power, injectable access ports, launched by B. Braun Melsungen offer high security and reliability to patients, nurses, doctors, and hospital administrators.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Parenteral Nutrition market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Baxter International Inc.
Grifols International S.A.
Actavis Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Hospira Inc.
Claris Lifesciences Limited
Sichuan Kelun Pharmaceutical
Pfizer
Aculife (Nirlife)

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2034

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Parenteral Nutrition Market Segmentation:

Nutrient Type Outlook:
Carbohydrates
Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals

Consumer Type Outlook:
Children and New-born
Adults

End-use Outlook:
Hospital
Clinic
Others
Geographic Segment Covered in the Report:

The Parenteral Nutrition report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)

Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/parenteral-nutrition-market

Key market aspects are illuminated in the report:

Executive Summary: It covers a summary of the most vital studies, the Global Parenteral Nutrition market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.

Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Parenteral Nutrition market, the years measured, and the study points.
Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.

Manufacture by Region: This Global Parenteral Nutrition report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2034

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Fractional Flow Reserve Market @ https://www.biospace.com/article/fractional-flow-reserve-market-growth-2022-2028-rising-number-of-patients-suffering-from-cardiovascular-and-coronary-artery-diseases-blood-pressure-diabetes-and-obesity/

Skin Cancer Market @ https://www.biospace.com/article/skin-cancer-market-growth-2022-2028-increasing-strategic-alliances-between-firms-utilization-of-combination-medicines-for-treatment-and-technological-advancements/

Proton Therapy Market @ https://www.biospace.com/article/proton-therapy-market-growth-2022-2028-increasing-cancer-prevalence-growing-aging-population-rising-healthcare-expenditure-and-increasing-awareness-about-proton-therapy/

Injectable Sumatriptan Market @ https://www.biospace.com/article/injectable-sumatriptan-market-growth-2022-2028-rising-incidence-of-migraine-cases-all-over-the-world/

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.